MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cempra Company Profile (NASDAQ:CEMP)

Consensus Ratings for Cempra (NASDAQ:CEMP) (?)
Ratings Breakdown: 2 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $36.80 (129.28% upside)

Analysts' Ratings History for Cempra (NASDAQ:CEMP)
Show:
DateFirmActionRatingPrice TargetActions
6/24/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2016Needham & Company LLCReiterated RatingBuy$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2016Stifel NicolausLower Price TargetBuy$51.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Roth CapitalInitiated CoverageBuy$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Janney Montgomery ScottReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Leerink SwannReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016WBB SecuritiesReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2016Robert W. BairdReiterated RatingBuy$38.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/16/2015Morgan StanleyUpgradeEqual Weight -> Overweight$25.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015SunTrustReiterated RatingBuy$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Ladenburg ThalmannReiterated RatingBuy$17.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Cempra (NASDAQ:CEMP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/27/2016        
5/2/2016Q1($0.63)($0.61)$3.94 million$2.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2016Q4($0.59)($0.48)$3.89 million$5.79 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q315($0.52)($0.63)$4.70 million$2.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015Q2($0.42)($0.57)$4.21 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q1($0.43)($0.41)$2.90 million$13.96 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015Q414($0.49)($0.46)$3.19 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q314($0.56)($0.34)$7.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214($0.56)($0.49)$2.56 million$1.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q114($0.48)($0.51)$2.10 million$3.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.42)($0.51)$1.25 million$2.07 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313($0.29)($0.41)$0.46 million$1.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q3 2013($0.42)($0.16)$5.13 million$4.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312($0.24)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Cempra (NASDAQ:CEMP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166($0.61)($0.48)($0.56)
Q2 20166($0.68)($0.44)($0.58)
Q3 20165($0.78)($0.60)($0.70)
Q4 20166($0.94)$2.54$0.30
Q1 20171($0.91)($0.91)($0.91)
Q2 20171($0.83)($0.83)($0.83)
Q3 20171($0.68)($0.68)($0.68)
Q4 20171($0.56)($0.56)($0.56)
(Data provided by Zacks Investment Research)
Dividend History for Cempra (NASDAQ:CEMP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Cempra (NASDAQ:CEMP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/1/2016David MooreInsiderBuy500$16.18$8,090.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Dov A. Md GoldsteinDirectorSell842$30.06$25,310.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015David W. OldachinsiderSell10,000$30.27$302,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2015David W. OldachinsiderSell12,200$28.78$351,116.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/26/2015Garheng KongDirectorBuy2,830$17.43$49,326.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015Dov A Md GoldsteinDirectorSell50,000$35.74$1,787,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2014John JohnsonDirectorBuy10,000$9.10$91,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013P Sherrill NeffDirectorBuy265,000$7.00$1,855,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Cempra (NASDAQ:CEMP)
DateHeadline
06/27/16 03:04 PMWere Analysts Bullish Cempra Inc (NASDAQ:CEMP) This Week? - Engelwood Daily
06/27/16 03:04 PMStrong Sell Calls Recommendations For Cempra, Inc. (NASDAQ:CEMP) At 0 - Investor Newswire
06/27/16 08:50 AMCempra, Inc. breached its 50 day moving average in a Bearish Manner : CEMP-US : June 27, 2016 -
06/25/16 03:04 PMCempra Inc (NASDAQ:CEMP) target price bumped down to $47 as disclosed today by Stifel Nicolaus
06/25/16 07:02 AMNeedham Thinks Cempra Inc.'s Stock is Going to Recover - Analyst Ratings
06/23/16 11:09 AMCEMPRA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
06/22/16 07:53 AMCempra, Inc. (NASDAQ:CEMP) Current Analyst Ratings - Fiscal Standard
06/21/16 07:35 AM4 Red-Hot Biotech Stocks With Over 100% Upside Potential -
06/20/16 03:08 PMStrong Buy Calls Count For Cempra, Inc. (NASDAQ:CEMP) At 8 - Investor Newswire
06/19/16 07:45 AMCuretis N V : Announces Excellent Study Data and Multi-Region Launch of Unyvero BCU Blood Culture Application Cartridge
06/16/16 08:30 PMPress Release: Curetis Announces Excellent Study Data and Multi-Region Launch of Unyvero BCU Blood Culture Application Cartridge
06/16/16 06:30 AMCempra to Host Analyst and Investor Day on June 23, 2016 - [GlobeNewswire] - CHAPEL HILL, N.C., June 16, 2016-- Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, ...
06/15/16 03:15 PMRoth Capital Reinstates Cempra Inc to Buy - TheFounders Daily
06/15/16 07:56 AMGlobal Antibacterial Drugs Market Is Expected To Reach USD 5,056.3 Mn By 2022 – Credence Research
06/11/16 08:36 PMCan Cempra, Inc. (NASDAQ:CEMP) Keep Up with Analyst Expectations? - Investor Newswire
06/10/16 11:40 AM3 Reasons Why Cempra, Inc. Rallied 10.99% in May - Motley Fool
06/10/16 06:30 AMCempra Announces Solithromycin Presentations at ASM Microbe 2016 Conference - [GlobeNewswire] - CHAPEL HILL, N.C., June 10, 2016-- Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, ...
06/09/16 08:31 AM3 Reasons Why Cempra, Inc. Rallied 10.99% in May - Here's a look at the reasons why shares of Cempra jumped last month.
06/08/16 11:40 AMCEMPRA INC. (NASDAQ:CEMP) Financial Condition Compared to S&P 500 - CML News
06/06/16 07:42 AMWere Analysts Bullish Cempra Inc (NASDAQ:CEMP) This Week? - HNN
06/05/16 08:25 PMPerformance Review for Cempra, Inc. (NASDAQ:CEMP) - HNN
06/04/16 11:40 AMStock's Earnings Activity: USG Corporation (NYSE:USG), Cempra, Inc. (NASDAQ:CEMP) - Beacon Chronicle
06/03/16 09:14 PMNeurocrine Biosciences, Inc. (NASDAQ:NBIX), Cempra Inc (NASDAQ:CEMP) - NYSE Journal (press release)
06/03/16 11:48 AMTraders Alert: Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Cempra Inc (NASDAQ:CEMP) - NYSE Journal (press release)
06/02/16 11:57 AMTwo Stocks within Traders Limelight: Wright Medical Group N.V. (NASDAQ:WMGI) , Cempra, Inc. (NASDAQ:CEMP) - Street Updates - Two Stocks within Traders Limelight: Wright Medical Group N.V. (NASDAQ:WMGI) , Cempra, Inc. (NASDAQ:CEMP)Street UpdatesIn the past trading session, Cempra, Inc. (NASDAQ:CEMP) ended trading session higher at $19.14 with +1.86%. The company traded a volume of 978.08 thousand shares as comparison to average volume of 689.1 thousand shares. During the 52 –week ...and more »
06/02/16 11:57 AMHealthcare Stocks on the Move: Cempra Inc (NASDAQ:CEMP), Community Health Systems (NYSE:CYH) - NYSE Journal (press release) - Healthcare Stocks on the Move: Cempra Inc (NASDAQ:CEMP), Community Health Systems (NYSE:CYH)NYSE Journal (press release)On Wednesday, Shares of Cempra Inc (NASDAQ:CEMP), added 1.86% and closed at $19.14 in the last trading session. The last trading range of the stock ranges between $18.54 and $19.22. May 25, 2016 – Cempra, Inc. (CEMP), a clinical-stage ...Cempra to Present at the Jefferies 2016 Healthcare ConferenceVirtual-Strategy Magazineall 2 news articles »
06/02/16 07:00 AMCempra to Present at the Jefferies 2016 Healthcare Conference - [GlobeNewswire] - CHAPEL HILL, N.C., June 02, 2016-- Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, ...
06/01/16 03:16 PMTarget Price and Stock Performance Rundown for Cempra, Inc. (NASDAQ:CEMP) - HNN - Target Price and Stock Performance Rundown for Cempra, Inc. (NASDAQ:CEMP)HNNKeeping an eye on share activity using multiple views may be helpful when tracking stock performance. Equity investors have the ability to track short or long term share performance. During the latest trading session, Cempra, Inc. (NASDAQ:CEMP) shares ...and more »
06/01/16 11:44 AMBuy, Sell Or Hold Rating For Cempra, Inc. (NASDAQ:CEMP)? - Share Trading News - Buy, Sell Or Hold Rating For Cempra, Inc. (NASDAQ:CEMP)?Share Trading News02/25/2016 – Cempra, Inc. had its “outperform” rating reiterated by analysts at Robert W. Baird. They now have a USD 33 price target on the stock. 12/21/2015 – Cempra, Inc. had its “buy” rating reiterated by analysts at Needham & Company. They now have ...and more »
05/31/16 03:10 PMHealthcare Stocks in Target: Johnson & Johnson (NYSE:JNJ) , Cempra, Inc. (NASDAQ:CEMP) - Is stories - Is storiesHealthcare Stocks in Target: Johnson & Johnson (NYSE:JNJ) , Cempra, Inc. (NASDAQ:CEMP)Is storiesIn most recently trading session on 5/27/2016, Cempra, Inc. (NASDAQ:CEMP) climbed +2.07% while traded on 973.92 thousand shares versus it's an average volume of 686.39 thousand shares. The company recorded the last trade with the price of $18.26.and more »
05/30/16 09:30 PMUS Reports First Case of Last Resort Antibiotic-Resistant Superbug - Torrey said doctors have feared this superbug for some time, where bacteria has adapted to be resistant to certain types of antibiotics. Last month, the antibiotic-resistant strain was found in the urine of a 49-year-old Pennsylvania woman treated in an ...
05/30/16 09:30 PMCempra : Efficacy and safety of the new macrolide antibiotic 'T-4288' confirmed in Phase II clinical trial in Japan - 05/02 CEMPRA: seeks FDA approval for drug in time for 2017 flu season 05/02 CEMPRA, INC.: Results of Operations and Financial Condition, Other Events, Fina.. 05/02 CEMPRA: Completes NDA Submissions for Solithromycin in the Treatment of Communi..
05/29/16 06:51 PMCempra Inc (CEMP) PT Lowered to $23.00 - Let Me Know About This - Cempra Inc (CEMP) PT Lowered to $23.00Let Me Know About ThisCempra logo Cempra Inc (NASDAQ:CEMP) had its price target decreased by equities researchers at Janney Montgomery Scott from $29.00 to $23.00 in a research note issued to investors on Monday. The firm presently has a “neutral” rating on the stock.How Analysts Rated Cempra Inc (NASDAQ:CEMP) Last Week?HNNall 2 news articles »
05/27/16 07:15 PMEarnings Review and Stock Rundown for Cempra, Inc. (NASDAQ:CEMP) - Wall Street Hints and News - Earnings Review and Stock Rundown for Cempra, Inc. (NASDAQ:CEMP)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Cempra, Inc. (NASDAQ:CEMP) to post ...and more »
05/26/16 07:10 PMCempra Inc. (CEMP) is Trading Higher on Unusual Volume for May 24 - Equities.com - Cempra Inc. (CEMP) is Trading Higher on Unusual Volume for May 24Equities.comCempra Inc. (CEMP) experienced unusually high volume on May. 24, as the stock gained 5.56% to a closing price of $16.91. The stock saw 1.05 million shares trade hands over the course of the day on 6,960 trades. Given that the stock's average daily ...and more »
05/26/16 07:10 PMCompany Update (NASDAQ:CEMP): Cempra Inc Announces Successful Results in the Phase 2 Community Acquired ... - Smarter Analyst - Company Update (NASDAQ:CEMP): Cempra Inc Announces Successful Results in the Phase 2 Community Acquired ...Smarter AnalystCempra Inc (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, is jointly developing solithromycin for the Japanese market in ...Earnings Reports To Watch: Cempra, Inc (NASDAQ:CEMP)CWRU ObserverCempra (CEMP) Announces Positive Data from Solithromycin Phase 2 in JapanStreetInsider.comCempra Announces Successful Results in the Phase 2 Community Acquired Bacterial Pneumonia (CABP) Trial ...Nasdaqall 3 news articles »
05/26/16 12:12 AMNo Pain, Only Gain For INNL, FDA Panel Backs SNY, Wait Continues For SRPT - A phase II trial of investigational antibiotic Solithromycin in Japanese patients with community acquired bacterial pneumonia or CABP in short, conducted by Cempra Inc.'s (CEMP) partner Toyama Chemical has successfully met its safety and efficacy measures.
05/25/16 06:53 PMAnalyst Recommended Stocks: Cempra Inc (CEMP), Goldcorp Inc. (USA) (GG) - News Oracle - Analyst Recommended Stocks: Cempra Inc (CEMP), Goldcorp Inc. (USA) (GG)News OracleThe stock gained 5.56% and closed its last session at $16.91. The Company has the market capitalization of 828.52 Million. The 52-Week Range ranges between $14.03 and $46.99. The stock traded with the Volume of 1.05 Million in the last trading day ...and more »
05/25/16 06:53 PMMarket Movers Alert: Cempra, Inc. (NASDAQ:CEMP) , CytRx Corporation (NASDAQ:CYTR) - Street Updates - Market Movers Alert: Cempra, Inc. (NASDAQ:CEMP) , CytRx Corporation (NASDAQ:CYTR)Street UpdatesCempra, Inc. (NASDAQ:CEMP) accumulated +5.56%, closing at $16.91 after floating between $16.11 and $17.68. The company has market capitalization of $815.06M. It has twelve month low of $14.03 and twelve month high of $46.99. The recent traded ...and more »
05/25/16 03:49 PMCEMPRA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
05/25/16 03:30 PMCempra Announces Successful Results in the Phase 2 Community Acquired Bacterial Pneumonia (CABP) Trial Conducted by Japanese Partner, Toyama Chemical (a subsidiary of FUJIFILM Holdings Corporation) - [GlobeNewswire] - Solithromycin safety and efficacy further validated by Toyama. All efficacy outcome measures favored solithromycin. Management to host Q&A webcast and conference call tomorrow at 8:00 a.m. ET.
05/25/16 07:15 AMCempra, Inc. breached its 50 day moving average in a Bullish Manner : CEMP-US : May 25, 2016 -
05/25/16 12:21 AMCempra Inc. (CEMP) Jumps 5.56% on May 24 - Equities.com - Cempra Inc. (CEMP) Jumps 5.56% on May 24Equities.comCempra Inc. (CEMP) was among the biggest gainers on the Russell 2000 for Tuesday May 24 as the stock popped 5.56% to $16.91, representing a gain of $0.89 per share. Some 1.05 million shares traded hands on 6,960 trades, compared with an average ...and more »
05/21/16 12:03 AMShare Recap and Earnings Focus on Cempra, Inc. (NASDAQ:CEMP) - Wall Street Hints and News - Share Recap and Earnings Focus on Cempra, Inc. (NASDAQ:CEMP)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating Cempra, Inc.and more »
05/21/16 12:03 AMCempra Inc. (CEMP) Jumps 6.41% on May 20 - Equities.com - Cempra Inc. (CEMP) Jumps 6.41% on May 20Equities.comCempra Inc. (CEMP) was among the biggest gainers on the Russell 2000 for Friday May 20 as the stock popped 6.41% to $15.76, representing a gain of $0.95 per share. Some 559,661 shares traded hands on 3,933 trades, compared with an average daily ...and more »
05/19/16 06:57 PMBuy Calls Count For Cempra, Inc. (NASDAQ:CEMP) At 1 - Investor Newswire - Buy Calls Count For Cempra, Inc. (NASDAQ:CEMP) At 1Investor NewswireCempra, Inc. (NASDAQ:CEMP) has a total of 7 Strong Buy recommendations and 0 Strong Sell calls as of 2016-05-18. One month ago, the count of strong buy ratings were 7 and strong sell ratings were 0. The mean analyst score was 1.45. A month earlier, 1 ...and more »
05/19/16 06:57 PMForm 8-K CEMPRA, INC. For: May 18 - StreetInsider.com - Form 8-K CEMPRA, INC. For: May 18StreetInsider.comThe 2016 annual meeting of stockholders for Cempra, Inc. was held on May 18, 2016. At the meeting, our stockholders elected two Class II members to our board of directors, each for a three-year term expiring at the annual meeting of stockholders in ...
05/19/16 07:42 AMCEMPRA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/17/16 11:51 PMCempra Inc. (CEMP) is Trading Higher on Unusual Volume for May 16 - Equities.com - Cempra Inc. (CEMP) is Trading Higher on Unusual Volume for May 16Equities.comCempra Inc. (CEMP) experienced unusually high volume on May. 16, as the stock gained 5.29% to a closing price of $15.53. The stock saw 982,959 shares trade hands over the course of the day on 8,027 trades. Given that the stock's average daily volume ...
05/17/16 11:51 PMRevenue Update on Cempra Inc(NASDAQ:CEMP) - Trade Calls - Revenue Update on Cempra Inc(NASDAQ:CEMP)Trade CallsCempra Inc(NASDAQ:CEMP) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 2, 2016. Company reported revenue of $2.68M. Analysts estimated a revenue of $3.94M. Earnings per share were ...
About Cempra

Cempra logoCempra Inc. is a clinical-stage pharmaceutical company focused on developing differentiated antibiotics for the acute care and community settings to meet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic staphylococcal infections. The Company's lead product, solithromycin, is being developed in oral capsules, intravenous, or IV, and suspension formulations, initially for the treatment of community acquired bacterial pneumonia, or CABP, an infection of the respiratory tract. The Company's second product is Taksta, an antibiotic known as fusidic acid, that has been used for decades outside the United States, including Western Europe, but , which has never been approved in the United States. The Company is developing Taksta in the United States as an oral treatment of refractory bone and joint infections caused by staphylococci.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: CEMP
  • CUSIP: 15130J10
Key Metrics:
  • Previous Close: $16.02
  • 50 Day Moving Average: $17.47
  • 200 Day Moving Average: $19.44
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $772.16M
  • Current Quarter EPS Consensus Estimate: $-2.54 EPS
Additional Links:
Cempra (NASDAQ:CEMP) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha